News and Trends 24 Mar 2023
Metabolism of RNA linked to leukemia
Researchers at Lund University Faculty of Medicine in Sweden have determined a novel mechanism linking the metabolism of ribonucleic acids,…
RNA technology
- Latest Posts
News and Trends 2 Mar 2023
Partnership formed to develop miRNA to treat pancreatic cancer
RNA delivery and therapeutics company SiSaf Ltd is to collaborate with the University of Leipzig in Germany to develop targeted…
News and Trends 6 Jan 2023
Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs
Orbit Discovery Limited has entered into a master service agreement with SanegeneBio Inc., a start-up company dedicated to developing novel…
News and Trends 12 Dec 2022
Japanese research offers hope for Fukuyama muscular dystrophy patients
Fukuyama congenital muscular dystrophy (FCMD) is the second most common form of childhood muscular dystrophy in Japan. The disease manifests…
ADVERTISEMENT
News and Trends 28 Nov 2022
STORM Therapeutics doses first patient with drug targeting solid tumors
STORM Therapeutics Ltd, announced today that the first patient in a phase 1 study had been dosed with a drug…
News and Trends 23 Nov 2022
BIA and Exopharm sign joint research agreement to develop integrated technology
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working with transformative medicines using exosomes,…
News and Trends 31 Oct 2022
Scientists say RNA production inhibitors important in cancer research
A study by researchers at the Biomedical Institute of Seville (IBIS) and the University of Seville, in collaboration with the…
News and Trends 12 Oct 2022
SiSaf takes steps with FDA for RNA therapeutic to treat rare genetic skeletal disorders
SiSaf Ltd, an RNA delivery and therapeutics company, is initiating the U.S. FDA Regulatory process to obtain orphan drug designation…
News and Trends 12 Oct 2022
Ascidian Therapeutics launches with $50M to rewrite RNA
Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, has been launched. With an initial focus…
News and Trends 7 Oct 2022
Ziphius and UZ Ghent collaborating on manufacture of saRNA-based vaccines
Ziphius Vaccines, a biopharmaceutical company developing vaccines and therapeutics based on self-amplifying RNA (saRNA), and UZ Ghent have entered a…
ADVERTISEMENT
News and Trends 20 Sep 2022
Regen BioPharma files patent on new RNA/DNA-based approach to cancer immunotherapy
Regen BioPharma, Inc. has filed a provisional patent application with the USPTO entitled "Dual Checkpoint Inhibitor Aptamer Based Therapeutics." The…
News and Trends 19 Sep 2022
Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy
The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a…
News and Trends 12 Sep 2022
SiSaf reveals positive preclinical data in siRNA program to treat osteopetrosis
SiSaf Ltd, an RNA delivery and therapeutics company, has announced positive data confirming safety and efficacy of its Bio-Courier next…
News and Trends 7 Sep 2022
Benchling launches solution to boost mRNA and RNA therapeutics development
Benchling has launched what it says is the industry’s first full set of capabilities for designing, modeling, and studying natural…
News and Trends 24 Aug 2022
Gene therapies for lung cancer identified by international team of scientists
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international team of scientists have discovered.…
News and Trends 17 Aug 2022
AUM LifeTech secures $400,000 grant for lung cancer immunotherapy program
AUM LifeTech, Inc., a Philadelphia-based preclinical stage biotech company, has received a Small Business Innovation Research (SBIR) grant from the…
ADVERTISEMENT
News and Trends 3 Aug 2022
siRNA company Eleven Therapeutics seals $22M funding
Eleven Therapeutics has raised a total of $22 million in seed funding. Among the roster of funders is the Bill…
In Depth 22 Jul 2022
The coming of age story of RNAi technology
The first RNA interference (RNAi) therapy was approved in 2018, after 20 years in development. What can we expect to…
News and Trends 20 Jul 2022
ICL and PlantArcBio look to use RNAi to boost crop yields
ICL, a global specialty minerals company, and ag-biotech company PlantArcBio, Ltd., have announced the development of a novel bio-stimulant technology…
News and Trends 11 Jul 2022
Study results reveal bleeding episodes are significantly reduced by hemophilia drug
People suffering from a severe blood disorder may only have to take a once-monthly drug following successful results from an…